Enabling access to molecular monitoring for chronic myeloid leukemia patients is cost effective in China.

Autor:	Maheshwari, Vikalp Kumar1 (AUTHOR), Slader, Cassandra2 (AUTHOR), Dani, Nidhi3 (AUTHOR), Gkitzia, Christina3 (AUTHOR), Yuan, Quan4 (AUTHOR), Xiong, Tengbin5 (AUTHOR), Liu, Yu6 (AUTHOR), Viana, Ricardo7 (AUTHOR) Ricardo.Viana@novartis.com
Zdroj:	PLoS ONE. 10/25/2021, Vol. 16 Issue 10, p1-17. 17p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu